The interplay of solvent-drug-protein interactions during albumin nanoparticles formulations for temozolomide delivery to brain cancer cells
Helal, Dina; Abdel-Mottaleb, Mona M A; Kamel, Amany O; Rouatbi, Nadia; Han, Shunping; Geneidi, Ahmed-Shawky; Al-Jamal, Khuloud T; Awad, Gehanne A S;
Abstract
Temozolomide (TMZ), the first line for glioma therapy, suffers from stability at physiological pH. TMZ was selected as a challenging model drug for loading into human serum albumin nanoparticles (HSA NPs). Our aim is to optimise the conditions for TMZ loading into HSA NPs while ensuring TMZ stability.
Other data
| Title | The interplay of solvent-drug-protein interactions during albumin nanoparticles formulations for temozolomide delivery to brain cancer cells | Authors | Helal, Dina ; Abdel-Mottaleb, Mona M A; Kamel, Amany O; Rouatbi, Nadia; Han, Shunping; Geneidi, Ahmed-Shawky; Al-Jamal, Khuloud T; Awad, Gehanne A S | Keywords | cytotoxicity; glioma; human serum albumin; nanoparticles; optimisation; temozolomide | Issue Date | 5-Jul-2023 | Journal | Journal of Pharmacy and Pharmacology | ISSN | 00223573 | DOI | 10.1093/jpp/rgad020 | PubMed ID | 37279781 | Scopus ID | 2-s2.0-85164243957 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.